Intelvio is transforming healthcare education by providing flexible, hands-on training for aspiring professionals in ...

A panelist discusses how they prioritize specific clinical and laboratory parameters when assessing response to first-line therapy in patients with polycythemia vera (PV) requiring combined phlebotomy ...

Vitestro today launched its Aletta autonomous robotic phlebotomy device (ARPD) that performs automated blood draws.

Takeda and Protagonist Therapeutics have reported positive topline outcomes from their Phase III VERIFY trial of rusfertide as an add-on to standard of care treatment for polycythaemia vera (PV) in ...

Phlebotomy Technicians are essential to proper healthcare worldwide as they are responsible for drawing blood needed for tests, donations, transfusions, and research. As the population ages and ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Aletta™, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™) in action: two devices with two patients and one supervisor. Aletta is named in honor of Dr. Aletta Jacobs ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

DocGo, a mobile health services provider, has acquired PTI Health, a company specialising in mobile lab collection and phlebotomy services in the mid-Atlantic region. This move aims to address the ...

Rusfertide outperformed placebo in polycythemia vera, meeting all primary and secondary end points in the phase 3 VERIFY ...

This phlebotomy training programme in adult venepuncture will incorporate academic learning in addition to practical application. The period of training lasts up to 3 months, leading to an assessment ...

Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta, the first ...